Login / Signup

Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis.

David De BandtSarah R HaileLouise DevillersBastien BourrionDominik Menges
Published in: BMJ mental health (2024)
We provide evidence that the COVID-19 pandemic may have had long-lasting consequences on the prevalence and treatment of depression and anxiety disorders, requiring further actions by researchers and policy-makers to address this potential public mental health crisis.
Keyphrases
  • mental health
  • public health
  • healthcare
  • risk factors
  • major depressive disorder
  • depressive symptoms
  • emergency department
  • human health
  • replacement therapy
  • data analysis